Results of the diagnostic efficacy, reliability and safety of gadoteric acid in 44,456 patients
| Autor: | Hackenbroch, Matthias |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: | |
| DOI: | 10.1594/ecr2018/c-0607 |
| Popis: | Aims and objectives Methods and materials Results Conclusion Personal information References Aims and objectives: Between January 2011 and December 2013, Guerbet carried out a non-interventional post-marketing surveillance (PMS) study on its Magnetic Resonance Imaging (MRI) contrast agent Dotarem® (gadoteric acid) in 52 centres. The aim of the PMS study was to... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|